Skip to search formSkip to main contentSkip to account menu

DL 111-IT

Known as: DL111-IT 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
OBJECTIVE To investigate the effects of antiangiogenesis of DL111-IT in vivo and in vitro.METHODS To detect the inhibition ratio… 
2005
2005
Aim: To identify proteins that are differentially expressed in cells derived from normal and diseased tunica albuginea (TA) as… 
2005
2005
Aim To develop an HPLC method with fluorescence d et ection for the assay of DL111-IT in rabbit plasma. Methods DL1 11-IT and… 
2002
2002
Objectives:To observe the effects of DL111 IT on uterine contractivity of pregnant rats in vitro .Methods:The drugs were dropped… 
2000
2000
AIM To observe the effects of DL111 IT on decidual cells, content of PGE 2 and PGF 2α , and uterine contractibility of pregnant… 
1997
1997
AIM To study the influence of DL111-IT on progesterone biosynthesis of cultured luteal cells (LC). METHODS LC viability was… 
1997
1997
目的:研究抗孕唑(DL111IT)对离体大鼠黄体细胞孕酮合成和存活率的影响.方法:体外培养大鼠黄体细胞,用细胞计数和放射免疫法.结果:DL111IT使黄体细胞存活率随剂量上升而下降,ED50为77(71-85)mg·L-1.DL111IT3mg·L-1使黄体细胞基础黄体酮分泌下降25%,并可显著抑制弗司扣林(cAMP激动剂)10μmol·L-1和孕烯醇酮(可被3βHSD催化成黄体酮)10μmol·L-1的促孕酮分泌作用,抑制率分别为43%和155%,但不抑制hCG10IU·L-1的促黄体酮分泌作用.结论:DL111IT抗早孕作用是在cAMP和3βHSD水平上影响基础黄体酮分泌功能,并于高剂量降低黄体细胞成活率.